Tyra Biosciences, Inc.
Key Metrics
Market Snapshot
About
Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing precision medicines that target fibroblast growth factor receptors (FGFRs). The company is advancing a pipeline of selective FGFR inhibitors designed to treat patients with cancer and other serious diseases. Tyra utilizes its proprietary SNÅP platform to design highly selective kinase inhibitors.